Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
30 aug 2016 - 07:00
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug reports financial results for H1 2016
Bericht
Probiodrug reports financial results for H1 2016
HALLE (SAALE), Germany, 30 August 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), today announced its financial results for the first six months ending 30 June 2016, prepared in accordance with German GAAP ("HGB") and, on a voluntary basis, in accordance with IFRS as endorsed by the European Union. The reports are available on the company website (http://www.probiodrug.de/investors/reports-and-presentations/).
Datum laatste update: 01 september 2024